Staphopains modulate staphylococcus aureus biofilm integrity

Infection and Immunity

Volumn 81, Issue 9, 2013, Pages 3227-3238

  Mootz, Joe M ^a   Malone, Cheryl L ^a   Shaw, Lindsey N ^b   Horswill, Alexander R ^a  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE PROTEASE SCPA; CYSTEINE PROTEASE SSPB; CYSTEINE PROTEINASE; N [N (3 CARBOXYOXIRANE 2 CARBONYL)LEUCYL]AGMATINE; PROTEINASE; SIGMA FACTOR; STAPHOPAIN; UNCLASSIFIED DRUG;

ARTICLE; ASSAY; BIOFILM; CONTROLLED STUDY; DELETION MUTANT; ENZYME ACTIVITY; GENE DELETION; NONHUMAN; PHENOTYPE; PLASMA COATED MICROTITER ASSAY; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAPHYLOCOCCUS AUREUS;

EID: 84884278572     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00377-13     Document Type: Article

References (67)

1. Kiedrowski MR, Horswill AR. 2011. New approaches for treating staphylococcal biofilm infections. Ann. N. Y. Acad. Sci. 1241:104-121.
2. Brady RA, Leid JG, Calhoun JH, Costerton JW, ShirtliffME. 2008. Osteomyelitis and the role of biofilms in chronic infection. FEMS Immunol. Med. Microbiol. 52:13-22.
3. Parsek MR, Singh PK. 2003. Bacterial biofilms: an emerging link to disease pathogenesis. Annu. Rev. Microbiol. 57:677-701.
4. Costerton JW. 2005. Biofilm theory can guide the treatment of devicerelated orthopaedic infections. Clin. Orthop. Relat. Res. 2005:7-11.
5. del Pozo JL, Patel R. 2007. The challenge of treating biofilm-associated bacterial infections. Clin. Pharmacol. Ther. 82:204-209.
6. Patel R. 2005. Biofilms and antimicrobial resistance. Clin. Orthop. Relat. Res. 2005:41-47.
7. Lauderdale KJ, Malone CL, Boles BR, Morcuende J, Horswill AR. 2010. Biofilm dispersal of community-associated methicillin-resistant Staphylococcus aureus on orthopedic implant material. J. Orthop. Res. 28:55-61.
8. Boles BR, Horswill AR. 2008. agr-mediated dispersal of Staphylococcus aureus biofilms. PLoS Pathog. 4:e1000052. doi:10.1371/journal.ppat.1000052.
9. Martí M, Trotonda MP, Tormo-Mas MA, Vergara-Irigaray M, Cheung AL, Lasa I, Penades JR. 2010. Extracellular proteases inhibit proteindependent biofilm formation in Staphylococcus aureus. Microbes Infect. 12:55-64.
10. O'Neill E, Pozzi C, Houston P, Humphreys H, Robinson DA, Loughman A, Foster TJ, O'Gara JP. 2008. A novel Staphylococcus aureus biofilm phenotype mediated by the fibronectin-binding proteins, FnBPA and FnBPB. J. Bacteriol. 190:3835-3850.
11. Kiedrowski MR, Kavanaugh JS, Malone CL, Mootz JM, Voyich JM, Smeltzer MS, Bayles KW, Horswill AR. 2011. Nuclease modulates biofilm formation in community-associated methicillin-resistant Staphylococcus aureus. PLoS One 6:e26714. doi:10.1371/journal.pone.0026714.
12. McGavin MJ, Zahradka C, Rice K, Scott JE. 1997. Modification of the Staphylococcus aureus fibronectin binding phenotype by V8 protease. Infect. Immun. 65:2621-2628.
13. Dubin G. 2002. Extracellular proteases of Staphylococcus spp. Biol. Chem. 383:1075-1086.
14. Nickerson N, Ip J, Passos DT, McGavin MJ. 2010. Comparison of Staphopain A (ScpA) and B (SspB) precursor activation mechanisms reveals unique secretion kinetics of proSspB (Staphopain B), and a different interaction with its cognate Staphostatin, SspC. Mol. Microbiol. 75:161-177.
15. Nickerson NN, Joag V, McGavin MJ. 2008. Rapid autocatalytic activation of the M4 metalloprotease aureolysin is controlled by a conserved N-terminal fungalysin-thermolysin-propeptide domain. Mol. Microbiol. 69:1530-1543.
16. Drapeau GR. 1978. Role of metalloprotease in activation of the precursor of staphylococcal protease. J. Bacteriol. 136:607-613.
17. Massimi I, Park E, Rice K, Muller-Esterl W, Sauder D, McGavin MJ. 2002. Identification of a novel maturation mechanism and restricted substrate specificity for the SspB cysteine protease of Staphylococcus aureus. J. Biol. Chem. 277:41770-41777.
18. Schroeder K, Jularic M, Horsburgh SM, Hirschhausen N, Neumann C, Bertling A, Schulte A, Foster S, Kehrel BE, Peters G, Heilmann C. 2009. Molecular characterization of a novel Staphylococcus aureus surface protein (SasC) involved in cell aggregation and biofilm accumulation. PLoS One 4:e7567. doi:10.1371/journal.pone.0007567.
19. Conrady DG, Brescia CC, Horii K, Weiss AA, Hassett DJ, Herr AB. 2008. A zinc-dependent adhesion module is responsible for intercellular adhesion in staphylococcal biofilms. Proc. Natl. Acad. Sci. U. S. A. 105:19456-19461.
20. Corrigan RM, Rigby D, Handley P, Foster TJ. 2007. The role of Staphylococcus aureus surface protein SasG in adherence and biofilm formation. Microbiology 153:2435-2446.
21. Merino N, Toledo-Arana A, Vergara-Irigaray M, Valle J, Solano C, Calvo E, Lopez JA, Foster TJ, Penades JR, Lasa I. 2009. Protein A-mediated multicellular behavior in Staphylococcus aureus. J. Bacteriol. 191:832-843.
22. Abraham NM, Jefferson KK. 2012. Staphylococcus aureus clumping factor B mediates biofilm formation in the absence of calcium. Microbiology 158:1504-1512.
23. Trotonda MP, Manna AC, Cheung AL, Lasa I, Penades JR. 2005. SarA positively controls bap-dependent biofilm formation in Staphylococcus aureus. J. Bacteriol. 187:5790-5798.
24. Huseby MJ, Kruse AC, Digre J, Kohler PL, Vocke JA, Mann EE, Bayles KW, Bohach GA, Schlievert PM, Ohlendorf DH, Earhart CA. 2010. Beta toxin catalyzes formation of nucleoprotein matrix in staphylococcal biofilms. Proc. Natl. Acad. Sci. U. S. A. 107:14407-14412.
25. O'Gara JP. 2007. ica and beyond: biofilm mechanisms and regulation in Staphylococcus epidermidis and Staphylococcus aureus. FEMS Microbiol. Lett. 270:179-188.
26. Archer NK, Mazaitis MJ, Costerton JW, Leid JG, Powers ME, ShirtliffME. 2011. Staphylococcus aureus biofilms: properties, regulation, and roles in human disease. Virulence 2:445-459.
27. Boles BR, Horswill AR. 2011. Staphylococcal biofilm disassembly. Trends Microbiol. 19:449-455.
28. Wang R, Khan BA, Cheung GY, Bach TH, Jameson-Lee M, Kong KF, Queck SY, Otto M. 2011. Staphylococcus epidermidis surfactant peptides promote biofilm maturation and dissemination of biofilm-associated infection in mice. J. Clin. Invest. 121:238-248.
29. Lauderdale KJ, Boles BR, Cheung AL, Horswill AR. 2009. Interconnections between Sigma B, agr, and proteolytic activity in Staphylococcus aureus biofilm maturation. Infect. Immun. 77:1623-1635.
30. Pané-Farré J, Jonas B, Forstner K, Engelmann S, Hecker M. 2006. The sigmaB regulon in Staphylococcus aureus and its regulation. Int. J. Med. Microbiol. 296:237-258.
31. BischoffM, Dunman P, Kormanec J, Macapagal D, Murphy E, Mounts W, Berger-Bachi B, Projan S. 2004. Microarray-based analysis of the Staphylococcus aureus sigmaB regulon. J. Bacteriol. 186:4085-4099.
32. Schenk S, Laddaga RA. 1992. Improved method for electroporation of Staphylococcus aureus. FEMS Microbiol. Lett. 73:133-138.
33. Novick RP. 1991. Genetic systems in staphylococci. Methods Enzymol. 204:587-636.
34. Vagner V, Dervyn E, Ehrlich SD. 1998. A vector for systematic gene inactivation in Bacillus subtilis. Microbiology 144(Pt 11):3097-3104.
35. Bae T, Schneewind O. 2006. Allelic replacement in Staphylococcus aureus with inducible counter-selection. Plasmid 55:58-63.
36. Kavanaugh JS, Thoendel M, Horswill AR. 2007. A role for type I signal peptidase in Staphylococcus aureus quorum-sensing. Mol. Microbiol. 65:780-798.
37. Wörmann ME, Reichmann NT, Malone CL, Horswill AR, Grundling A. 2011. Proteolytic cleavage inactivates the Staphylococcus aureus lipoteichoic acid synthase. J. Bacteriol. 193:5279-5291.
38. Reed SB, Wesson CA, Liou LE, Trumble WR, Schlievert PM, Bohach GA, Bayles KW. 2001. Molecular characterization of a novel Staphylococcus aureus serine protease operon. Infect. Immun. 69:1521-1527.
39. Nickerson EK, Wuthiekanun V, Wongsuvan G, Limmathurosakul D, Srisamang P, Mahavanakul W, Thaipadungpanit J, Shah KR, Arayawichanont A, Amornchai P, Thanwisai A, Day NP, Peacock SJ. 2009. Factors predicting and reducing mortality in patients with invasive Staphylococcus aureus disease in a developing country. PLoS One 4:e6512. doi:10.1371/journal.pone.0006512.
40. Nakamura C, Miyamoto C, Obataya I, Takeda S, Yabuta M, Miyake J. 2007. Enzymatic nanolithography of FRET peptide layer using V8 protease-immobilized AFM probe. Biosens. Bioelectron. 22:2308-2314.
41. Wladyka B, Puzia K, Dubin A. 2005. Efficient co-expression of a recombinant staphopain A and its inhibitor staphostatin A in Escherichia coli. Biochem. J. 385:181-187.
42. Ko KY, Ahn DU. 2007. Preparation of immunoglobulin Y from egg yolk using ammonium sulfate precipitation and ion exchange chromatography. Poult. Sci. 86:400-407.
43. Cassat JE, Lee CY, Smeltzer MS. 2007. Investigation of biofilm formation in clinical isolates of Staphylococcus aureus. Methods Mol. Biol. 391:127-144.
44. Pang YY, Schwartz J, Thoendel M, Ackermann LW, Horswill AR, Nauseef WM. 2010. agr-dependent interactions of Staphylococcus aureus USA300 with human polymorphonuclear neutrophils. J. Innate Immun. 2:546-559.
45. Francois P, Schrenzel J, Stoerman-Chopard C, Favre H, Herrmann M, Foster TJ, Lew DP, Vaudaux P. 2000. Identification of plasma proteins adsorbed on hemodialysis tubing that promote Staphylococcus aureus adhesion. J. Lab. Clin. Med. 135:32-42.
46. François P, Vaudaux P, Lew PD. 1998. Role of plasma and extracellular matrix proteins in the physiopathology of foreign body infections. Ann. Vasc Surg. 12:34-40.
47. Walker JN, Horswill AR. 2012. A coverslip-based technique for evaluating Staphylococcus aureus biofilm formation on human plasma. Front. Cell. Infect. Microbiol. 2:39.
48. Beenken KE, Mrak LN, Griffin LM, Zielinska AK, Shaw LN, Rice KC, Horswill AR, Bayles KW, Smeltzer MS. 2010. Epistatic relationships between sarA and agr in Staphylococcus aureus biofilm formation. PLoS One 5:e10790. doi:10.1371/journal.pone.0010790.
49. Tsang LH, Cassat JE, Shaw LN, Beenken KE, Smeltzer MS. 2008. Factors contributing to the biofilm-deficient phenotype of Staphylococcus aureus sarA mutants. PLoS One 3:e3361. doi:10.1371/journal.pone.0003361.
50. Potempa J, Dubin A, Korzus G, Travis J. 1988. Degradation of elastin by a cysteine proteinase from Staphylococcus aureus. J. Biol. Chem. 263:2664-2667.
51. Zong Y, Mazmanian SK, Schneewind O, Narayana SV. 2004. The structure of sortase B, a cysteine transpeptidase that tethers surface protein to the Staphylococcus aureus cell wall. Structure 12:105-112.
52. Filipek R, Rzychon M, Oleksy A, Gruca M, Dubin A, Potempa J, Bochtler M. 2003. The Staphostatin-staphopain complex: a forward binding inhibitor in complex with its target cysteine protease. J. Biol. Chem. 278:40959-40966.
53. Ohbayashi T, Irie A, Murakami Y, Nowak M, Potempa J, Nishimura Y, Shinohara M, Imamura T. 2011. Degradation of fibrinogen and collagen by staphopains, cysteine proteases released from Staphylococcus aureus. Microbiology 157:786-792.
54. Laarman AJ, Mijnheer G, Mootz JM, van Rooijen WJ, Ruyken M, Malone CL, Heezius EC, Ward R, Milligan G, van Strijp JA, de Haas CJ, Horswill AR, van Kessel KP, Rooijakkers SH. 2012. Staphylococcus aureus Staphopain A inhibits CXCR2-dependent neutrophil activation and chemotaxis. EMBO J. 31:3607-3619.
55. Rohde H, Burandt EC, Siemssen N, Frommelt L, Burdelski C, Wurster S, Scherpe S, Davies AP, Harris LG, Horstkotte MA, Knobloch JK, Ragunath C, Kaplan JB, Mack D. 2007. Polysaccharide intercellular adhesin or protein factors in biofilm accumulation of Staphylococcus epidermidis and Staphylococcus aureus isolated from prosthetic hip and knee joint infections. Biomaterials 28:1711-1720.
56. Chaignon P, Sadovskaya I, Ragunah C, Ramasubbu N, Kaplan JB, Jabbouri S. 2007. Susceptibility of staphylococcal biofilms to enzymatic treatments depends on their chemical composition. Appl. Microbiol. Biotechnol. 75:125-132.
57. O'Neill E, Pozzi C, Houston P, Smyth D, Humphreys H, Robinson DA, O'Gara JP. 2007. Association between methicillin susceptibility and biofilm regulation in Staphylococcus aureus isolates from device-related infections. J. Clin. Microbiol. 45:1379-1388.
58. Iwase T, Uehara Y, Shinji H, Tajima A, Seo H, Takada K, Agata T, Mizunoe Y. 2010. Staphylococcus epidermidis Esp inhibits Staphylococcus aureus biofilm formation and nasal colonization. Nature 465:346-349.
59. Kantyka T, Shaw LN, Potempa J. 2011. Papain-like proteases of Staphylococcus aureus. Adv. Exp. Med. Biol. 712:1-14.
60. Doern CD, Roberts AL, Hong W, Nelson J, Lukomski S, Swords WE, Reid SD. 2009. Biofilm formation by group A Streptococcus: a role for the streptococcal regulator of virulence (Srv) and streptococcal cysteine protease (SpeB). Microbiology 155:46-52.
61. Kolar SL, Antonio Ibarra J, Rivera FE, Mootz JM, Davenport JE, Stevens SM, Horswill AR, Shaw LN. 2013. Extracellular proteases are key mediators of Staphylococcus aureus virulence via the global modulation of virulence-determinant stability. Microbiologyopen 2:18-34.
62. Datsenko KA, Wanner BL. 2000. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc. Natl. Acad. Sci. U. S. A. 97:6640-6645.
63. Nair D, Memmi G, Hernandez D, Bard J, Beaume M, Gill S, Francois P, Cheung AL. 2011. Whole-genome sequencing of Staphylococcus aureus strain RN4220, a key laboratory strain used in virulence research, identifies mutations that affect not only virulence factors but also the fitness of the strain. J. Bacteriol. 193:2332-2335.
64. Baba T, Takeuchi F, Kuroda M, Yuzawa H, Aoki K, Oguchi A, Nagai Y, Iwama N, Asano K, Naimi T, Kuroda H, Cui L, Yamamoto K, Hiramatsu K. 2002. Genome and virulence determinants of high virulence community-acquired MRSA. Lancet 359:1819-1827.
65. Boles BR, Thoendel M, Roth AJ, Horswill AR. 2010. Identification of genes involved in polysaccharide-independent Staphylococcus aureus biofilm formation. PLoS One 5:e10146. doi:10.1371/journal.pone.0010146.
66. Lin YC, Anderson MJ, Kohler PL, Strandberg KL, Olson ME, Horswill AR, Schlievert PM, Peterson ML. 2011. Proinflammatory exoprotein characterization of toxic shock syndrome Staphylococcus aureus. Biochemistry 50:7157-7167.
67. Bateman BT, Donegan NP, Jarry TM, Palma M, Cheung AL. 2001. Evaluation of a tetracycline-inducible promoter in Staphylococcus aureus in vitro and in vivo and its application in demonstrating the role of sigB in microcolony formation. Infect. Immun. 69:7851-7857.